Summary Data from the Cancer Registries of the Swiss Cantons of Vaud and Neuchatel were analysed to examine possible associations between skin cancers (including basal cell carcinoma, BCC), non-Hodgkin's lymphomas (NHL) and chronic lymphocytic leukaemias (CLL). Between 1974 and 1993, 1767 cases of NHL, 351 of CLL, 1678 of cutaneous malignant melanoma (CMM), 4131 of squamous cell carcinoma (SCC) and 10 575 of BCC were registered, and contributed to a total of 120 103 person -years at risk. Following NHL, 36 cases of SCC were registered compared with 5.1 expected, corresponding to a standardised incidence ratio (SIR) of 7.0 (95% confidence interval, CI, 4.9-9.7); 37 cases of BCC were observed compared with 10.2 expected (SIR = 3.6; 95% CI 2.6-5.0). Following CLL, nine cases of SCC were observed compared with 1.8 expected (SIR=5.0; 95% CI 2.3-9.5) and nine cases of BCC were observed compared with 3.3 expected (SIR = 2.7; 95% CI 1.2-5.2). After SCC, 23 cases at NHL were observed compared with 9.0 expected (SIR=2.6; 95% CI 1.6-3.8); after BCC, 43 cases of NHL were registered compared with 22.5 expected (SIR= 1.9; 95% CI 1.4-2.6); and after CMM, four cases of NHL were observed compared with 2.0 expected (SIR=2.0). No significant excess of CLL was recorded following skin cancer, but the absolute numbers were small and the SIR was above unity. The findings of this study, conducted in populations with a high level of ascertainment and registration of skin cancers, confirm an excess of skin cancers including BCC, following NHL and CLL, and an excess of NHL following skin cancers. This may be related to shared aetiological factors such as U.V. radiation and associated immunosuppression. Individual-based data on the relationship between U.V. exposure and lymphoid neoplasms are needed to clarify the issue.
The incidence of non-Hodgkin's lymphomas (NHL) and of the related chronic lymphocytic leukaemias (CLL) has substantially increased over the last few decades in most areas of the world (Devesa and Fears, 1992 ; Hartge and Carli et al., 1994; Hartge et al., 1994; Levi et al., 1995a; Hjalgrim et al., 1996) . A proportion of this increase is due to improved diagnosis and certification, but this alone cannot adequately explain such a systematic and substantial rise.
Immunodepression has been related to lymphomas, and an immunodepressant effect of U.V. radiation has been reported in experimental conditions (Hartge and Devesa, 1992; Cartwright et al., 1994; Doll, 1996) . Furthermore, a few studies from the Nordic countries, North America and The Netherlands have reported excess incidence of melanoma and non-melanomatous skin cancers following NHL or CLL, and of NHL or CLL following skin cancer (Travis et al., 1992 (Travis et al., , 1993 Adami et al., 1995; Hall et al., 1995; Frisch and Melbye, 1995) . The evidence, however, is not totally consistent as no excess of NHL was observed after melanoma in Denmark (Swerdlow et al., 1995) . In addition, ecological studies on populations in the UK (Bentham, 1996) and on a worldwide scale (McMichael and Giles, 1996) , but not within the United States (Hartge et al., 1996) , are suggestive of a shared influence of U.V. exposure (on a population level) on NHL and skin neoplasms.
In a systematic analysis of multiple primary cancers in Vaud, Switzerland, between 1974 and 1989 (Levi et al., 1993 , an excess of non-melanomatous skin cancer was observed after NHL and leukaemias in both sexes. We decided, therefore, to update the analysis with specific focus on various histotypes of skin cancer and lymphoid neoplasms.
Correspondence: F Levi Received 14 June 1996; revised 8 July 1996; accepted 8 July 1996 This was made possible by specific attention to identification and registration of various histotypes of skin cancer, including squamous cell carcinoma (SCC), basal cell carcinoma (BCC) and cutaneous malignant melanoma (CMM) (Levi et al., 1995b) .
Materials and methods
The present analysis is based on the Vaud and Neuchatel Cancer Registries files, which include information concerning incident cases of malignant neoplasms in these cantons (whose populations, according to the 1990 census, were about 600 000 and 160 000 respectively; Levi et Pellaux et al., 1992) .
Notification is based on a voluntary agreement between the recording medical institutions of the cantons and the registries. All Calculation of expected numbers was based on sex-, ageand calendar year-specific incidence rates multiplied by the observed number of person-years at risk. The end of the follow-up was determined by a second primary, death, emigration or the end of the study period at 31 December 1994. The significance of the observed/expected ratios (standardised incidence ratio, SIR) was based on the Poisson distribution applied to the observed numbers (Breslow and Day, 1987) . aComprises basal cell and squamous cell carcinomas, and malignant melanomas (n = 2).
Results
was appreciably, although not significantly, larger in women (SIR = 9.2) than in men (SIR = 5.0), but similar in strata of duration of follow-up. When two separate age groups were considered, risk was higher below age 75 (SIR= 16.5; 95% CI 9.2-27.2) than at age 75 or over (SIR=5.0; 95% CI 3.1-7.6). A total of 37 cases of BCCs were observed compared with 10.2 expected, corresponding to a SIR of 3.6 (95% CI 2.6-5.0). Significant heterogeneity was only observed across the two separate strata of age at diagnosis considered, the SIR being 6.7 below age 75 and 2.2 at age 75 or over. With reference to all skin cancers, 74 cases were observed compared with 16.6 expected (SIR=4.5, 95% CI 3.5-5.6). Following CLL, nine cases of SCC were observed compared with 1.8 expected (SIR= 5.0; 95% CI 2.3-9.5), nine cases of BCC compared with 3.3 expected (SIR=2.7; 95% CI 1.2-5.2) and 19 cases of all skin cancers combined compared with 5.5 expected (SIR=3.5; 95% CI 2.1-5.4). The SIR was higher for men (5.1) than for women (0.8), after shorter duration of follow-up (SIR = 4.8; <5 years vs 1.4>5 years), and for the younger age group (SIR= 8.7; <75 years vs 2.4 > 75 years), although these differences were not significant.
Corresponding information on lymphoid neoplasms following major histotypes of skin cancer is shown in Table  III . After SCC, 23 cases of NHL were observed compared with 9.0 expected (SIR=2.6; 95% CI 1.6-3.8).
No heterogeneity was observed between men and women, across age groups or durations of follow-up. Only four cases of CLL were observed compared with 2.7 expected and, thus, no excess risk emerged for SCC.
A total of 43 cases of NHL were observed after BCC compared with 22.5 expected, corresponding to a SIR of 1.9 (95% CI 1.4-2.6). With the exception of age at diagnosis, no appreciable heterogeneity was observed across strata of sex or durations of follow-up. After SCC, four cases of CLL were observed compared with 2.7 expected (SIR= 1.5; 95% CI 0.4 -3.8), whereas no appreciable CLL excess was observed after BCC (SIR= 1.1; 95% CI 0.4-2.2). After CMM, four cases of NHL were observed (SIR = 2.0) and one case of CLL (SIR= 1.9). None of these estimates was significant.
Discussion
The findings of this study, conducted in populations with high standards of ascertainment, diagnosis and certification of skin cancer (Levi et al., 1995b) , confirm that there is an excess of skin cancers (including BCC) following lymphoid neoplasms (NHL and CLL) and an excess of NHL following skin cancer. The relationship was observed for both SCC and BCC, but was somewhat stronger for SCC. A consistent pattern of risk was observed with CMM, too, but the data were too scanty for any significant result. The lower risk of skin cancer following CLL may be due to the low number of cases, or may indicate a reduced association compared with that observed with NHL.
Thus, the main contribution of this study is in showing that not only SCC and CMM, but also BCC (which is seldom registered in cancer registration schemes), is related to NHL and CLL. The associations were significant and consistent for BCC although somewhat less strong than for SCC.
Assuming that the underlying mechanism of the observed relationship between incidence of skin cancer and lymphoid neoplasms is U.V. radiation -and the consequent immunosupression of lymphoid neoplasms (Cartwright et al., 1994;  Hartge and Doll, 1996) -this may reflect a differential role of U.V. exposure on the incidence of SCC and BCC. Data from the same population (Franceschi et al., 1996) indicated that both histotypes were more common in frequently sun-exposed areas in both sexes, although the excess was greater for SCC. Other studies-conducted in Denmark and Sweden (Adami et al., 1995; Hall et al., 1995) Table In Observed (OBS) and expected (EXP) cases, and standardised incidence ratio (SIR) of subsequent non-Hodgkin's lymphoma and chronic lymphocyctic leukaemia (CLL) after an initial diagnosis of skin cancer in the cantons of Vaud and Neuchatel, Switzerland, 1974-93 Subsequent non-Hodgkin's lymphoma Non-Hodgkin's lymphomas and skin cancers F Levi et al 1850 also showed a stronger association between NHL and SCC (with SIR of the order of 5) than for CMM (SIR around or below 2). The latter estimate was also consistent with that of a cohort of more than 6171 cases of NHL collected in various areas of North America and Europe (Travis et al., 1993) . A common aetiological correlate, U.V. exposure or other factors causing immunosuppression (Cartwright et al., 1994; Sasieni and Bataille, 1995) , appears, therefore, to be a likely explanation of the association observed. This is also consistent with certain descriptive features of skin neoplasms and lymphomas, including their upward trends over the last few decades in most developed countries (Devesa and Fears, 1992; Hartge and Devesa, 1992; Carli et al., 1994; Levi et al., 1995a,b; Hjalgrim et al., 1996) and geographic correlational studies in the UK (Bentham, 1996; McMichael and Giles, 1996) , although not in the US (Hartge et al., 1996) . Moreover, there is a lack of individual-based information on any potential relationship between sun -and other sources of U.V. exposure -and the risk of lymphoid neoplasms. Before any such data are available, any inference on aetiological correlates should be considered speculative.
Increased surveillance and diagnosis following another neoplasm should also be considered. Although this could be a reasonable interpretation for at least part of the skin cancer excess following lymphoma, it is unlikely that a past history of SCC or BCC would materially modify subsequent ascertainment and diagnosis of lymphomas and CLL. Furthermore, no systematic excess of any cancer sites was observed: following skin melanoma the SIR for any site was 1.1 for men and 0.8 for women; following non-melanomas 1.0 for both; and following lymphomas 1.3 for men and 1.0 for women (Levi et al., 1993) .
The absence of any clear pattern of risk with increasing time after diagnosis of the first neoplasm is also incompatible with a major role of ascertainment or diagnostic bias. Among the other advantages of this study are its population basis, the inclusion of various histotypes of skin cancer, which should render any estimate relatively free from selection bias, and the complete histological confirmation of the various types of neoplasms considered.
In conclusion, therefore, this study on a population that was particularly well surveyed for skin cancers (Levi et al., 1995b) confirms the presence of an association between SCC, NHL and, although less strongly, CLL. For the first time, these data also demonstrated an association between BCC, NHL and CLL, supporting the hypothesis that common aetiological factors are a determinant of the increased incidence of various types of skin and lymphoid neoplasms. The accumulating evidence on the issue has relevance to prevention
